...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of Siwu Decoction on Primary Dysmenorrhea and Molecular Docking Verification
【24h】

Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of Siwu Decoction on Primary Dysmenorrhea and Molecular Docking Verification

机译:网络药理学策略探讨Siwu汤对原发性痛经和分子对接验证的药理学机制

获取原文
           

摘要

Objective . To study the pharmacological mechanisms of Siwu decoction (SWD) on primary dysmenorrhea (PDM) and verify with molecular docking. Methods . The ?Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was utilized to acquire the active compounds and their corresponding target genes. The GeneCards database was utilized in the search for target genes that were associated with PDM. The intersection genes from the active target genes of SWD and those associated with PDM represented the active target genes of SWD that act on PDM. The Gene Ontology (GO) function enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were both carried out by RGUI 3.6.1 and Cytoscape 3.6.0 software. Cytoscape was also utilized for creating a compound-target network, and a protein-protein interaction (PPI) network was created through the STRING database. Molecular docking simulations of the macromolecular protein target receptors and their corresponding compounds were performed using AutoDockTool 1.5.6 and AutoDock Vina software. Results . We identified 14 active compounds as well as 97 active target genes of SWD by using the TCMSP. We compared the 97 active target genes of SWD to the 299 target genes related to PDM, and 23 active target genes for SWD that act on PDM which correlated with 11 active compounds were detected. The compound-target network as well as the PPI network were created, in addition to selecting the most essential compounds and their targets in order to create a key compound-target network. The most essential compounds were kaempferol, beta-sitosterol, stigmasterol, and myricanone. The key targets were AKT1, PTGS2, ESR1, AHR, CASP3, and PGR. Lastly, molecular docking was used to confirm binding of the target with its corresponding compound. Conclusion . The pharmacological mechanisms of SWD that act on PDM were investigated, and the active compounds in the SWD for treating PDM were further verified.
机译:客观的 。为了研究原发性痛经(PDM)四物汤(SWD)的药理学机制,并用分子对接验证。方法 。本?中国传统医药系统药理学数据库和分析平台(TCMSP)的资金用于收购的活性化合物及其相应的靶基因。所述GeneCards数据库被利用在所述搜索该用PDM相关的靶基因。从SWD和与PDM相关联的那些的活性靶基因的交点基因代表SWD的上PDM行为活性的靶基因。通过RGUI 3.6.1和3.6.0的Cytoscape软件基因本体论(GO)功能的丰富和京都基因与基因组百科(KEGG)通路富集分析是双方进行。 Cytoscape的还用于创建复合目标网络,和蛋白质 - 蛋白质相互作用(PPI)网络是通过STRING数据库中创建。大分子蛋白靶受体和它们的相应的化合物的分子对接模拟使用AutoDockTool 1.5.6和AUTODOCK维娜软件进行。结果 。我们确定了14的活性化合物以及通过使用TCMSP SWD的97活性的靶基因。我们比较了97种活性目标SWD的于与PDM 299个靶基因的基因SWD和23活性的靶基因已检测到作用于PDM与11的活性化合物相关。化合物 - 目标网络以及所述PPI网络被创建,在除了选择以创建密钥化合物-目标网络的最重要的化合物和它们的靶标。最重要的化合物是山奈酚,β-谷甾醇,豆甾醇,和myricanone。关键的目标是AKT1,PTGS2,ESR1,AHR,CASP3和PGR。最后,分子对接被用来确认与其相应的化合物的靶的结合。结论 。 SWD的药理学机制上PDM行为进行了研究,并在SWD用于治疗PDM的活性化合物进一步验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号